BIOSOLVE‐IV ‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients-Reference-Cited by-同舟云学术

BIOSOLVE‐IV ‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients

Published:2020-09-03 Issue:1 Volume:98 Page:
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Verheye Stefan¹^ORCID,Wlodarczak Adrian²,Montorsi Piero³,Torzewski Jan⁴,Bennett Johan⁵^ORCID,Haude Michael⁶^ORCID,Starmer Gregory⁷,Buck Thomas⁸,Wiemer Marcus⁹,Nuruddin Amin A. B.¹⁰,Yan Bryan P.‐Y.¹¹^ORCID,Lee Michael K.‐Y.¹²

Affiliation:

1. Interventional Cardiology ZNA Cardiovascular Center Middelheim Antwerp Belgium

2. Miedziowe Centrum Zdrowia S.A. Lubin Poland

3. Department of Clinical Sciences and Community Health University of Milan and Centro Cardiologico Monzino, IRCCS Milan Italy

4. Cardiovascular Center Oberallgäu‐Kempten Kempten Germany

5. Department of Cardiovascular Medicine University Hospitals Leuven Leuven Belgium

6. Medical Clinic I Städtische Kliniken Neuss Lukaskrankenhaus GmbH Neuss Germany

7. Department of Cardiology Cairns Hospital Cairns Australia

8. Department of Cardiology Herz Zentrum Westfalen, Klinikum Westfalen Dortmund Germany

9. Department of Cardiology and Intensive Care Johannes Wesling University Hospital Ruhr University Bochum Minden Germany

10. Department of Cardiology Institute Jantung Negara Kuala Lumpur Malaysia

11. Division of Cardiology, Department of Medicine and Therapeutics Prince of Wales Hospital Hong Kong Hong Kong

12. Division of Cardiology Queen Elizabeth Hospital Kowloon Hong Kong

Funder

Biotronik

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.29260

Reference30 articles.

1. State of the art: the inception, advent and future of fully bioresorbable scaffolds

2. A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis

3. Five-Year Clinical and Functional Multislice Computed Tomography Angiographic Results After Coronary Implantation of the Fully Resorbable Polymeric Everolimus-Eluting Scaffold in Patients With De Novo Coronary Artery Disease

4. Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold

5. Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synchrotron microtomography reveals insights into the degradation kinetics of bio-degradable coronary magnesium scaffolds;Bioactive Materials;2024-02

2. Development and Future Trends of Protective Strategies for Magnesium Alloy Vascular Stents;Materials;2023-12-22

3. Resorbable magnesium metal membrane for sinus lift procedures: a case series;BMC Oral Health;2023-12-14

4. Comparison of acute versus stable coronary syndrome in patients treated with the Magmaris scaffold: Two-year results from the Magmaris Multicenter Italian Registry;Cardiovascular Revascularization Medicine;2023-12

5. Rational design, synthesis and prospect of biodegradable magnesium alloy vascular stents;Journal of Magnesium and Alloys;2023-09